I’m sharing this story now, more than eight years after her diagnosis, because a notorious vaccine skeptic may soon lead the ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV ...

Evaxion Biotech has completed subject dosing in the Phase II trial of its personalised peptide-based cancer vaccine, EVX-01, ...

When Kristen Dahlgren left journalism to launch a cancer vaccine initiative, she never imagined it would reconnect her with ...

New research published in the New England Journal of Medicine has shown a single dose of the influenza vaccine is sufficient ...

A consultant and president of a cancer support charity hopes to raise take-up rates of the human papillomavirus (HPV) vaccine among boys. Maz Darji, a radiology consultant at Northampton General ...

Discover how the HPV vaccine is changing cancer prevention for both men and women with remarkable protection rates.

Trial remains on track for completion and data readout in the second half of 2025COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S ...

Delray Beach, FL, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, reaching US$10.61 billion ...

Cervical cancer is one of the most preventable and treatable forms of cancer when caught early, thanks to effective screening ...

Evaxion Biotech A/S (EVAX), a clinical-stage TechBio company specializing in AI-driven vaccines, has announced the completion of ...